ME-13 LOSS OF SOCS3 IN MYELOID CELLS DELAYS TUMOR GROWTH AND PROLONGS SURVIVAL IN A SYNGENEIC MODEL OF GLIOBLASTOMA

Glioblastoma (GBM), a particularly devastating type of brain tumor, remains a challenging and difficult disease to treat. Despite aggressive therapies, patients diagnosed with GBM have a median survival of 12-16 months. On a cellular level, GBM tumors are extremely heterogeneous, consisting of resid...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: McFarland, Braden C., Marks, Margaret P., Rowse, Amber L., Gerigk, Magda, Walker, Phyllis M., Qin, Hongwei, Benveniste, Etty N.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2014
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218296/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou261.12
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires